Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

NCT00355407 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

DRUG: Darbepoetin alfa

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]